Abiopharma

🔍 Aljomaih Automotive Co. (Executive)

Company: Xos, Inc. (XOS)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Sold 125,000 shares of Convertible Note at $12.0 per share (Derivative)
  Date: 2026-08-11 | Code: J | Expires: 2028-02-11 | equity_swap_involved: false | shares_owned_after: 1,166,666.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4, F3, F2, F5

Footnotes:

• F1: On August 11, 2026, the issuer made a scheduled repayment of $1.5 million principal amount of the Convertible Note.
• F2: The $1.5 million principal amount repaid was convertible into an aggregate of 125,000 shares of common stock, par value $0.0001 per share, of the issuer.
• F3: The principal amount plus any accrued and unpaid interest was convertible at the holder's election after November 9, 2022.
• F4: $1.5 million principal amount of the Convertible Note was repaid and extinguished for face value.
• F5: The $14,000,000 principal amount of Convertible Notes outstanding immediately following the transaction was convertible into 1,166,666 shares of Common Stock at $12.00 per share. Column 9 does not include any interest accrued on the Convertible Note since August 11, 2025 (at a rate of 10% per annum), which may be converted into Interest Shares at the 10-day VWAP on the date of payment.